Medical Editor: John P. Cunha, DO, FACOEP
What Is NephroScan?
NephroScan (kit for the preparation of technetium Tc 99m succimer injection) after radiolabeling with technetium Tc 99m, is a radioactive diagnostic agent indicated for use as an aid in the scintigraphic evaluation of renal parenchymal disorders in adults and pediatric patients including term neonates.
What Are Side Effects of NephroScan?
Side effects of NephroScan include:
- fever, and
Dosage for NephroScan
The recommended amount of radioactivity by intravenous injection (bolus) for adults is 74 MBq to 222 MBq (2 mCi to 6 mCi). The recommended amount of radioactivity by intravenous injection (bolus) for pediatric patients is 1.85 MBq/kg (0.05 mCi/kg) of body weight with a range of 19 MBq to 74 MBq (0.5 mCi to 2 mCi).
NephroScan In Children
NephroScan, after radiolabeling with technetium Tc 99m, is indicated for use as an aid in the scintigraphic evaluation of renal parenchymal disorders in pediatric patients, including term neonates.
What Drugs, Substances, or Supplements Interact with NephroScan?
NephroScan may interact with other medicines.
Tell your doctor all medications and supplements you use.
NephroScan During Pregnancy and Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant before using NephroScan; it is unknown how it could affect a fetus. Although all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose, the radiation exposure to the fetus from technetium Tc 99m succimer is expected to be low (less than 0.50 mGy). NephroScan is present in breast milk. Temporarily discontinue breastfeeding. A lactating woman should pump and discard breastmilk for at least 24 hours after NephroScan administration.
Our NephroScan (kit for the preparation of technetium Tc 99m succimer injection), for Intravenous Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
The following clinically significant adverse reactions are discussed elsewhere in the labeling:
- Hypersensitivity Reactions [see WARNINGS AND PRECAUTIONS]
The following adverse reactions associated with the use of NEPHROSCAN were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Immune System Disorders: Hypersensitivity including urticaria, rash, pruritus, and erythema
General Disorders: syncope, fever, and nausea.
No Information Provided
Read the entire FDA prescribing information for NephroScan (Technetium Tc 99m Succimer Injection)
© NephroScan Patient Information is supplied by Cerner Multum, Inc. and NephroScan Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
Health Solutions From Our Sponsors